Hims & Hers Shares Plunge as Amazon Enters Telehealth Arena

November 14, 2024, delivered a devastating blow to Hims & Hers Health investors as the company’s stock value collapsed by more than 25% in a single trading session. This dramatic sell-off was triggered by Amazon’s strategic move into the telehealth sector, directly challenging the core revenue streams that have driven Hims & Hers’ financial performance.

The e-commerce behemoth launched a new telemedicine service exclusively for Prime members, featuring transparent flat-rate pricing across more than thirty healthcare categories. This initiative includes medical consultations, treatment plans, and complimentary medication delivery through Amazon Pharmacy. Crucially, Amazon is targeting the precise therapeutic areas—specifically male pattern hair loss and erectile dysfunction—that generate over Read more...